Capital Allocators• Apr 28, 2025• 41:54Interview

Rodrigo Bitar - Overlooked Opportunities in Latin America (EP.442)

From Capital Allocators

Rodrigo Bitar

Executive Summary

Latin America presents an attractive investment case due to favorable valuations, a young population, and increasing geopolitical alignment with the U.S.
in a multipolar world.
Venezuela offers a unique, high-risk/high-reward environment for distressed asset investing, where an informal dollarization has stabilized the economy, allowing for the acquisition of quality assets at sub-4x EBITDA multiples.
A successful private equity strategy in Venezuela involves a roll-up of fragmented, essential industries like pharmaceuticals, demonstrated by growing a company from the sixth to the second-largest market player through strategic acquisitions (including Pfizer's local assets).
The primary investment risk in these markets is illiquidity, which is managed by focusing on high-quality, cash-flowing assets and targeting high annual dividend yields (20%+) to de-risk the investment over a long-term holding period.

12 quotes

Concerns Raised

The primary risk is asset illiquidity, requiring a long-term and patient investment horizon with no clear short-term exit path.
Unpredictable shifts in U.S. policy towards Venezuela, particularly regarding oil sanctions, could impact the macroeconomic environment.
Difficulty in convincing family-owned businesses to sell at deeply discounted valuations, requiring significant relationship-building and value-add propositions.

Opportunities Identified

Acquiring high-quality, strategic assets in Venezuela at deeply discounted valuations, specifically sub-4x EBITDA.
Executing a roll-up strategy in fragmented, essential-goods industries like pharmaceuticals to create market leaders and achieve scale.
Leveraging the stabilizing effect of the informal dollarization of the Venezuelan economy, which underpins local consumption growth and business planning.
Capitalizing on the lack of available credit, where providing capital for working capital and acquisitions is a major competitive advantage.

Key Themes

Distressed Investing in Venezuela

Venezuela represents a contrarian investment opportunity where a severe macroeconomic shock and perceived political risk have created a market with deeply discounted, high-quality assets. The informal dollarization of the economy since 2019 has provided a crucial layer of stability, enabling a recovery in local consumption and business growth.

This highlights an asymmetric risk-reward profile for investors with high risk tolerance and local expertise, allowing the acquisition of strategic assets at a fraction of their regional value before foreign capital potentially returns.

Private Equity Roll-up Strategy in Frontier Markets

The speaker details a classic private equity playbook applied in a distressed market: acquiring a platform company in a fragmented sector (pharmaceuticals) and aggressively growing it through add-on acquisitions. This strategy leverages access to scarce capital and transactional expertise to consolidate the market and build a dominant player.

This demonstrates a tangible method for value creation in an otherwise challenging environment, showing how operational and M&A expertise can drive significant growth and create strategic assets independent of the broader political situation.

The Geopolitical Significance of the Americas

As the world shifts towards distinct geopolitical blocs, Latin America's historical, cultural, and economic proximity to the U.S. becomes a strategic advantage. This integration is reinforced by favorable trade agreements and minimal negative impact from recent global tariff shifts, positioning the Americas as a more cohesive economic unit.

This geopolitical tailwind strengthens the long-term investment case for the region, suggesting increased stability, nearshoring opportunities, and deeper economic integration with North America.

Managing Illiquidity and Exit Risk

The primary risk in markets like Venezuela is not political volatility but rather the illiquidity of assets. The investment strategy explicitly addresses this by targeting cash-flow-generating assets and aiming for high annual dividend yields (20%+) to de-risk the investment over a patient, long-term holding period.

This provides a practical framework for investing in frontier or distressed markets, emphasizing patience and cash flow generation as the primary tools to mitigate the uncertainty of a future exit event, which is contingent on the return of foreign strategic buyers.

Latin American Pharmaceutical Market Dynamics

The pharmaceutical sector in the region, particularly in Venezuela, is characterized by a focus on branded and unbranded generics, operating more like a consumer goods business than a research-intensive one. These companies exhibit attractive financial profiles with high margins (30-35%) and low capital expenditures, making them ideal targets for consolidation.

This identifies a specific, resilient sector with strong fundamentals that is well-suited for private equity investment, offering both defensive qualities and significant growth potential through M&A-driven strategies.

Get started free

Topics

Latin America Venezuela Private Equity Distressed Investing Roll-up Strategy Pharmaceuticals Generics Valuation Multiples EBITDA Geopolitics US-Latin America Relations Illiquidity Risk Dollarization Emerging Markets M&A

Processed Apr 6, 2026 yt-dlp + mlx-whisper + Gemini